| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N06BX13 |
| UNII: | HB6PN45W4J |
| InChI Key | JGPMMRGNQUBGND-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H30O5 |
| Molecular Weight | 338.44 |
| AlogP | 3.46 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 12.0 |
| Polar Surface Area | 72.83 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 24.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 27 | |
|
Enzyme
Transferase
|
- | 1900 | - | - | - | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class III
|
- | 15400 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Muscular Dystrophy, Duchenne | 3 | D020388 | ClinicalTrials |
| Friedreich Ataxia | 3 | D005621 | ClinicalTrials |
| Optic Atrophy, Hereditary, Leber | 3 | D029242 | ClinicalTrials |
| MELAS Syndrome | 2 | D017241 | ClinicalTrials |
| Huntington Disease | 1 | D006816 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 1 | D065626 | ClinicalTrials |
| Multiple Sclerosis, Chronic Progressive | 1 | D020528 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 58186-27-9 |
| ChEBI | 31687 |
| ChEMBL | CHEMBL252556 |
| DrugCentral | 1416 |
| EPA CompTox | DTXSID0040678 |
| FDA SRS | HB6PN45W4J |
| PubChem | 3686 |
| SureChEMBL | SCHEMBL28320 |
| ZINC | ZINC000001542890 |